Kamada Ltd.
A biopharmaceutical company specializing in plasma-derived protein therapeutics.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-15 14:27 |
FORM 20-F For the fiscal year ended December 31, 2022
|
English | 36.2 KB | ||
| 2023-03-15 14:18 |
Kamada Reports Strong Fiscal Year and Fourth Quarter 2022 Financial Results, an…
|
English | 1.2 MB | ||
| 2023-03-15 14:18 |
Kamada Reports Strong Fiscal Year and Fourth Quarter 2022 Financial Results, an…
|
English | 36.2 KB | ||
| 2023-03-15 14:11 |
The company's financial results for 2022 reported abroad
|
Hebrew (modern) | 61.6 KB | ||
| 2023-03-09 16:35 |
Kamada to Announce Fourth Quarter and Full Year 2022 Financial Results and Host…
|
English | 119.6 KB | ||
| 2023-03-09 16:35 |
Kamada to Announce Fourth Quarter and Full Year 2022 Financial Results and Host…
|
English | 36.1 KB | ||
| 2023-01-04 15:03 |
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOG…
|
English | 171.7 KB | ||
| 2023-01-04 15:03 |
Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOG…
|
English | 36.1 KB | ||
| 2022-12-22 17:16 |
Notice of Results of the 2022 Annual General Meeting of Shareholders held on De…
|
English | 111.7 KB | ||
| 2022-12-22 17:16 |
Notice of Results of the 2022 Annual General Meeting of Shareholders held on De…
|
English | 36.1 KB | ||
| 2022-12-19 15:01 |
Kamada Announces Planned Transition of Chief Financial Officer
|
English | 92.4 KB | ||
| 2022-12-19 15:01 |
Kamada Announces Planned Transition of Chief Financial Officer
|
English | 36.0 KB | ||
| 2022-11-22 15:04 |
Strong Third Quarter Financial Results Demonstrating Successful Strategic
Tran…
|
English | 273.2 KB | ||
| 2022-11-22 15:04 |
Strong Third Quarter Financial Results Demonstrating Successful Strategic
Tran…
|
English | 36.2 KB | ||
| 2022-11-17 21:40 |
Annual General Meeting on Thursday, December 22, 2022, at 2:00 p.m. (Israel tim…
|
English | 172.8 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kamada Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
